Dr. Ashish Sarraju and Dr. C. Michael Gibson discuss: Extremely Long Duration Lp(a) Reduction Following a Single Dose of Kylo-11: Final Data from a First-in-Human Study August 28, 2026 2026 | ESC | Slides | Trial | Video Sarraju_Kylo-11 ESC LBCT Aug 25 2026_with sim pub QR codeDownload Disclosures: TBD Article Navigation Dr. Luke Laffin and Dr. C. Michael Gibson discuss: Durability of Effects of CTX310, a CRISPR-Cas9 Gene Editing Targeting ANGPTL3 Dr. Deepak Bhatt and Dr. C. Michael Gibson discuss: TRANQUILITY: Efficacy of monthly and quarterly dosing of pacibekitug (IL-6 ligand mAb) targeting inflammation in CKD with high cardiovascular risk
